NCT04088227View on ClinicalTrials.gov

Effects of Platelet Rich Plasma Injections on Biomarkers After Anterior Cruciate Ligament Tears

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 12, 2019

Primary Completion Date

September 1, 2022

Study Completion Date

April 21, 2023

Conditions
Anterior Cruciate Ligament TearAnterior Cruciate Ligament Rupture
Interventions
DRUG

Experimental Group

Patients will receive platelet rich plasma injection two times prior to surgery.

OTHER

Control Group

Patients will have their knee aspirated at their initial physician visit and at the time of surgery.

Trial Locations (1)

32561

Andrews Institute for Orthopaedics & Sports Medicine, Gulf Breeze

All Listed Sponsors
lead

Andrews Research & Education Foundation

OTHER

NCT04088227 - Effects of Platelet Rich Plasma Injections on Biomarkers After Anterior Cruciate Ligament Tears | Biotech Hunter | Biotech Hunter